InventionMed S.A. (WSE:INM)

Poland · Delayed Price · Currency is PLN

0.1060

+0.0005 (0.47%)

At close: Jun 15, 2026

-39.43% (1Y)

Market Cap	21.50M -47.0%
Revenue (ttm)	3.74M +684.2%
Net Income	592.32K
EPS	0.00
Shares Out	202.79M
PE Ratio	36.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,567
Open	0.1040
Previous Close	0.1055
Day's Range	0.1010 - 0.1060
52-Week Range	0.0972 - 0.1890
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. The company flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. It also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. The company was incorporated in 2012 and is based in Bydgoszcz, Poland. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2012

Employees 4

Stock Exchange Warsaw Stock Exchange

Ticker Symbol INM

Full Company Profile

Financial Performance

In 2025, InventionMed's revenue was 3.17 million, an increase of 1041.56% compared to the previous year's 277,760. Losses were -749,410, -82.99% less than in 2024.

Financial Statements